6550 Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 

health policies under the control of 

Ministry of Health through the GHS 

Governing Council. GHS has the 

Mandate to provide and manage 

comprehensive and accessible health 

services with special emphasis on 

primary health care at regional, district, 

and sub-district levels. 

Summary of the Award 

Recipient: Ghana Health Service. 

Purpose of the Award: The purpose of 

this award is to build laboratory and SI 

capacity to improve the provision of 

HIV testing, treatment, and retention in 

line with HIV epidemic control and 95– 

95–95 targets. This award strives to 

build and strengthen laboratories with 

the appropriate diagnostic technologies, 

trained and skilled staff, and systems 

that can provide efficient services. It 

also strengthens SI systems, data quality 

assurance, and the capacity of staff 

responsible for managing facility-based, 

survey, and surveillance data operating 

at national and subnational levels. 

Amount of Award: The approximate 

year 1 funding amount will be $800,000 

in Federal Fiscal Year (FFY) 2022 funds, 

subject to the availability of funds. 

Funding amounts for years 2–5 will be 

set at continuation. 

Authority: This program is authorized 

under Public Law 108–25 (the United 

States Leadership Against HIV AIDS, 

Tuberculosis and Malaria Act of 2003). 

Period of Performance: September 30, 

2022 through September 29, 2027. 

Dated: February 1, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–02410 Filed 2–3–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement To Fund the 

National AIDS Control Program, 

Programme National de Lutte contre le 

VIH/SIDA (PNLS), Democratic Republic 

of Congo 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award of approximately $500,000 for 

Year 1 of funding to the Programme 

National de Lutte contre le VIH/SIDA 

(PNLS). The award will strengthen 

Strategic Information (SI) activities, 

laboratory quality assurance services, 

and surveillance of new infections in 

Democratic Republic of Congo (DRC). 

This support will enhance the 

antiretroviral therapy (ART) cohort 

monitoring and delivery of HIV/AIDS 

services for the epidemic control in 

DRC. Funding amounts for years 2–5 

will be set at continuation. 

DATES: The period for this award will be 

September 30, 2022 through September 

29, 2027. 

FOR FURTHER INFORMATION CONTACT: 

Kaee Ross, Center for Global Health, 

Centers for Disease Control and 

Prevention, U.S. Embassy DRC, 498 Ave 

Col Lukusa, Kinshasa, Gombe, DRC, 

Telephone: 800–232–6348, email: knr6@

cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

single-source award will improve data 

collection and analysis to produce a 

factual basis for evaluation and 

improvement of the HIV prevention, 

care, and treatment program in the DRC. 

The project will build capacity in DRC 

to have available, reliable data 

transmitted promptly for decisionmaking. Furthermore, the project will 

sustain quality assurance for rapid tests 

to ensure accuracy of results, and the 

monitoring of rapid tests used in the 

field. 

The PNLS is a specialized program 

run by the Ministry of Health (MOH) in 

the DRC. Created on August 5, 2015 by 

Ministerial Decision No. 449/MSLS/ 

CAB, the PNLS has been authorized and 

tasked to lead and coordinate the fight 

against the HIV/AIDS epidemic to 

achieve epidemic control. The PNLS is 

the governmental authority with the 

normative and regulatory role in the 

implementation of STI and HIV/AIDS 

control activities in the Health Zones 

(HZ). The PNLS has the authority to 

organize, review, and validate all data 

relative to HIV–AIDS in country. In 

addition, PNLS has the mission to 

control the quality of rapid test results 

provided by health care workers at 

facilities and to monitor how rapid tests 

are working in the field. Accordingly, 

PNLS has the sole authority and is 

uniquely qualified to perform the 

anticipated activities for this award. 

Summary of the Award 

Recipient: the Programme National de 

Lutte contre le VIH/SIDA (PNLS). 

Purpose of the Award: The purpose of 

this award is to strengthen SI activities, 

laboratory quality assurance services, 

and surveillance of new infections in 

DRC. Support from this award will 

enhance ART cohort monitoring and 

delivery of HIV/AIDS services for 

control of the epidemic in DRC. 

Amount of Award: The approximate 

year 1 funding amount will be $500,000 

in Federal Fiscal Year (FFY) 2022 funds, 

subject to the availability of funds. 

Funding amounts for years 2–5 will be 

set at continuation. 

Authority: This program is authorized 

under Public Law 108–25 (the United 

States Leadership Against HIV AIDS, 

Tuberculosis and Malaria Act of 2003). 

Period of Performance: September 30, 

2022 through September 29, 2027. 

Dated: February 1,2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–02411 Filed 2–3–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement To Fund the 

Sierra Leone Ministry of Health and 

Sanitation 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award of approximately $450,000 for 

Year 1 of funding to the Sierra Leone 

(SL) Ministry of Health and Sanitation. 

The award will build laboratory and 

Strategic Information (SI) capacity to 

improve the provision of HIV testing, 

treatment, and retention in line with 

HIV epidemic control and 95–95– 

95(95% of HIV-positive individuals 

knowing their status, 95% of those 

receiving ART [Antiretroviral therapy], 

and 95% of those achieving viral 

suppression) targets. Funding amounts 

for years 2–5 will be set at continuation. 

DATES: The period for this award will be 

September 30, 2022 through September 

29, 2027. 

FOR FURTHER INFORMATION CONTACT: 

Trong Ao, Center for Global Health, 

Centers for Disease Control and 

Prevention, CDC Ghana Office, U.S. 

Embassy, 24 Fourth Circular Road 

Cantonments, Accra, Ghana, Telephone: 

800–232–6348, Email: tfa8@cdc.gov. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 6551 

SUPPLEMENTARY INFORMATION: The 

single-source award will support the 

National AIDS Control Program of Sierra 

Leone (SL) in the Ministry of Health and 

Sanitation to implement HIV strategic 

information and laboratory 

strengthening activities in SL. This 

award will build and strengthen 

laboratories that are equipped with the 

appropriate diagnostic technologies, 

trained and skilled staff, and systems 

that have the capability to provide 

efficient services. It will also strengthen 

SI systems, data quality assurance and 

capacity of staff responsible for 

managing facility-based survey and 

surveillance data operating at national 

and subnational levels. As the mandated 

institution to provide HIV treatment 

clinical services and guidelines in SL, 

the Sierra Leone Ministry of Health and 

Sanitation is in a unique position to 

conduct this work. The National HIV/ 

AIDS control program is one of the 

specialized programs within the 

Ministry of Health. 

Summary of the Award 

Recipient: Sierra Leone Ministry of 

Health and Sanitation. 

Purpose of the Award: The purpose of 

this award is to build laboratory and SI 

capacity to improve the provision of 

HIV testing, treatment, and retention in 

line with HIV epidemic control and 95– 

95–95 targets. The award will build and 

strengthen laboratories that are 

equipped with the appropriate 

diagnostic technologies, trained and 

skilled staff, and systems that have the 

capability to provide efficient services. 

Amount of Award: The approximate 

year 1 funding amount will be $450,000 

in Federal Fiscal Year (FFY) 2022 funds, 

subject to the availability of funds. 

Funding amounts for years 2–5 will be 

set at continuation. 

Authority: This program is authorized 

under Public Law 108–25 (the United 

States Leadership Against HIV AIDS, 

Tuberculosis and Malaria Act of 2003). 

Period of Performance: September 30, 

2022 through September 29, 2027. 

Dated: February 1, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–02407 Filed 2–3–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

RFA–CE–22–013: Rigorous Evaluation 

of Community-Centered Approaches for 

the Prevention of Community Violence. 

Date: June 28–29, 2022. 

Time: 8:30 a.m.–5:30 p.m., EDT. 

Place: Videoconference. 

Agenda: To review and evaluate grant 

applications. 

FOR FURTHER INFORMATION CONTACT: 

Mikel Walters, Ph.D., Scientific Review 

Official, National Center for Injury 

Prevention and Control, CDC, 4770 

Buford Highway NE, Mailstop F–63, 

Atlanta, Georgia 30341, Telephone (404) 

639–0913, MWalters@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–02380 Filed 2–3–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Delegation of Authority 

Notice is hereby given that the 

Director, Centers for Disease Control 

and Prevention (CDC), has delegated to 

the Chief Operating Officer, CDC, 

without the authority to redelegate, the 

authority vested in the Secretary of HHS 

by section 212(1) of the Department of 

Defense and Labor, Health and Human 

Services, and Education Appropriations 

Act, 2019 and Continuing 

Appropriations Act, 2019 (FY 19 HHS 

Appropriations Act) Public Law 115– 

245, division B, title II, or substantially 

similar authorities vested in the 

Secretary in the future by Congress, in 

order to carry out international health 

activities. 

Section 212(1) of the FY19 HHS 

Appropriations Act permits the 

Secretary of HHS to exercise authority 

equivalent to that available to the 

Secretary of State under 22 U.S.C 

2669(c) to award personal services 

contracts for work performed in foreign 

countries. The authority delegated 

herein includes the authority to 

determine the necessity of negotiating, 

executing, and performing such 

contracts without regard to statutory 

provisions as related to the negotiation, 

making, and performance of contracts 

and performance of work in the United 

States. 

The authority under section 212(1) is 

immediately revoked in the event that 

any subsequent fiscal year HHS 

appropriations act does not contain the 

provision currently in section 212(1) or 

substantially similar authority. 

The Chief Operating Officer, CDC, 

shall consult with the Secretary of State 

and relevant Chief of Mission to ensure 

that this authority is exercised in a 

manner consistent with section 207 of 

the Foreign Service Act of 1980 and 

other applicable statutes administered 

by the Department of State. 

This delegation supersedes the 

delegation of similar name, approved by 

the Director, CDC, on March 17, 2020. 

This delegation became effective on 

January 31, 2022. The Director, CDC, 

affirms and ratifies any actions taken 

that involve the exercise of the authority 

delegated herein prior to the effective 

date of this delegation. 

Sherri A. Berger, 

Chief of Staff, Centers for Disease Control 

and Prevention. 

[FR Doc. 2022–02328 Filed 2–3–22; 8:45 am] 

BILLING CODE 4163–18–P 


lotter on DSK11XQN23PROD with NOTICES1